Related Experiment Video

Updated: Jun 14, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Continuous glucose monitoring in newborn babies at risk of hypoglycemia

Deborah L Harris1, Malcolm R Battin, Philip J Weston

  • 1Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.

The Journal of Pediatrics
|March 27, 2010
PubMed

Insights

Continuous glucose monitoring (CGM) is useful for detecting low glucose in newborns at risk. CGM identified significantly more low glucose events than traditional blood tests, though their clinical impact needs further study.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Medical Technology

Background:

  • Neonatal hypoglycemia is a common concern in high-risk infants.
  • Traditional intermittent blood glucose measurements may miss transient or prolonged hypoglycemic episodes.

Purpose of the Study:

  • To evaluate the utility of continuous glucose monitoring (CGM) in neonates at risk for hypoglycemia.
  • To compare CGM with standard blood glucose testing in this population.

Main Methods:

  • A prospective study involving 102 infants (>32 weeks gestation) at risk for hypoglycemia.
  • Infants received routine care with intermittent blood glucose measurements and blinded CGM.
  • Agreement between blood and interstitial glucose levels was assessed.

Main Results:

  • CGM was well-tolerated and showed good agreement with blood glucose levels.
  • CGM detected low glucose (<2.6 mmol/L) in more infants (44%) compared to blood sampling (32%).
  • CGM identified numerous low glucose episodes, including prolonged ones, that were missed by blood glucose measurements.

Conclusions:

  • Continuous glucose monitoring significantly increases the detection of low glucose episodes in at-risk newborns compared to intermittent blood sampling.
  • The clinical significance of the numerous undetected low glucose episodes identified by CGM requires further investigation.
Abstract

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...